Literature DB >> 20809033

Maturation of the neuromuscular junction in masseters of human fetus.

W Molina1, E Reyes, N Joshi, Ana Barrios, L Hernandez.   

Abstract

OBJECTIVES: The aim of the present investigation is to examine if the histological maturation of the neuromuscular junction in the masseters of human fetuses has already begun by the 12-th week of gestation or not.
MATERIAL AND METHODS: Twenty-four masseter muscles from 14 human fetuses at gestational age 12 weeks were divided into two groups. In the first group, muscle sections were stained with Bielschowsky and Holzer stains for examination of neurofibrils and glial cells respectively. In the second group, rhodamine and fluorescein conjugated alpha-bungarotoxin were used to detect nicotinic receptors and anti-GAD for neuronal terminals.
RESULTS: It was observed the presence of one axon for each end-plate and glial cells spread over a branched axon. The nicotinic receptors clustered in the neuromuscular junction, neuronal terminals and large oval nucleus were detected.
CONCLUSIONS: These observations suggest that the maturation of the neuromuscular junctions of the masseter muscles in the human fetuses has already begun at the 12-th week of gestation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809033

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  3 in total

1.  Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

Authors:  Abhishek Saxena; Jo Stevens; Hakan Cetin; Inga Koneczny; Richard Webster; Konstantinos Lazaridis; Socrates Tzartos; Kathleen Vrolix; Gisela Nogales-Gadea; Barbie Machiels; Peter C Molenaar; Jan Damoiseaux; Marc H De Baets; Katja Simon-Keller; Alexander Marx; Angela Vincent; Mario Losen; Pilar Martinez-Martinez
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

2.  Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.

Authors:  Yoshitsugu Nakamura; Hideto Nakajima; Takafumi Hosokawa; Kazushi Yamane; Shimon Ishida; Fumiharu Kimura
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

3.  Anti-glutamic acid decarboxylase antibody (GAD) syndromes may have more aggressive disease course in African Americans and early onset of presentation compare to Caucasians group.

Authors:  Shitiz Sriwastava; Meghana Srinivas; Anila Kanna; Kalyan Yarraguntla; Abbas Jowkar; Edwin George
Journal:  eNeurologicalSci       Date:  2019-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.